Equity Story are very excited to add RESApp Health Limited (RAP) as a new Ten bagger. We are very excited where this company could go.They are simply developing an App that can diagnose respiratory illnesses . The Apps aim is to diagnose Acute conditions URTIs, influenza, bronchi)s, bronchioli)s, pneumonia, pertussis, croup Chronic Conditions Asthma, COPD, cystic fibrosis, bronchiectasis
[/table]
RAP Price at posting:
9.0¢ Sentiment: Buy Disclosure: Held
